Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial

Our results suggest that an improvement in modulation of AGE metabolism, which facilitates better management of circulating AGE levels, may be one of the mechanisms through which the Mediterranean diet, compared to a low-fat diet, reduces the progression of atherosclerosis in patients with CHD. Trial registration https://clinicaltrials.gov/ct2/show/NCT00924937 , Clinicaltrials.gov number, NCT00924937.

Authors

Institutions

Publication Details

Journal
Cardiovascular Diabetology
Published
2024-10-14
DOI
https://doi.org/10.1186/s12933-024-02451-4
Citations
6
Primary Topic
Advanced Glycation End Products research
Type
article
Field-Weighted Citation Impact
2.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial

Raul Miguel Luque, Jaime Uribarri, Elena M. Yubero‐Serrano, José D. Torres‐Peña et al.
6 citations
Cardiovascular Diabetology
Advanced Glycation End Products research
2.29
article

Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial

Raul Miguel Luque, Jaime Uribarri, Elena M. Yubero‐Serrano, José D. Torres‐Peña, José López‐Miranda, Francisco M. Gutierrez‐Mariscal, Javier Delgado‐Lista, Antonio P. Arenas‐de Larriva, Pablo Pérez‐Martínez, Alejandro López‐Moreno, Purificación Gómez-Luna, Juan Luis Romero‐Cabrera
article en
6 citations

Abstract

Our results suggest that an improvement in modulation of AGE metabolism, which facilitates better management of circulating AGE levels, may be one of the mechanisms through which the Mediterranean diet, compared to a low-fat diet, reduces the progression of atherosclerosis in patients with CHD. Trial registration https://clinicaltrials.gov/ct2/show/NCT00924937 , Clinicaltrials.gov number, NCT00924937.

Cardiovascular DiabetologyVol. 23(1)
Instituto de Salud Carlos III (ES), Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (ES), Instituto de la Grasa (ES), Instituto Maimónides de Investigación Biomédica de Córdoba (ES), University of Córdoba (ES), Cordoba University (US), Icahn School of Medicine at Mount Sinai (US)
European Association of Social Psychology, Fundación Patrimonio Comunal Olivarero, European Commission, Ministerio de Ciencia e Innovación, Consejería de Salud y Familias, Junta de Andalucía, Junta de Andalucía, Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición, Servicio Andaluz de Salud, Instituto de Salud Carlos III, Agencia Estatal de Investigación
Good health and well-being
Openalex Percentile: Top 12%
Advanced Glycation End Products research
2.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.